Yonghong Zhang

Summary

Country: China

Publications

  1. doi The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection
    Yonghong Zhang
    Beijing You An Hospital, Capital Medical University, Beijing, PR China
    Antiviral Res 92:247-54. 2011
  2. pmc Characteristics of CD8+ T cell subsets in Chinese patients with chronic HIV infection during initial ART
    Yanmei Jiao
    Center for Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijng 100069, China
    AIDS Res Ther 8:15. 2011
  3. doi Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients
    Yonghong Zhang
    Beijing You An Hospital, Capital Medical University, Beijing, China
    Liver Int 32:102-9. 2012
  4. doi Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog
    Xinyue Chen
    Beijing You An Hospital, Capital Medical University, Beijing, China
    J Gastroenterol Hepatol 27:481-6. 2012
  5. doi Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment
    Wei Hua
    Center for Infectious Diseases, Beijing You An Hospital, Capital Medical University, China
    Immunol Invest 41:1-14. 2012
  6. pmc Multilayered defense in HLA-B51-associated HIV viral control
    Yonghong Zhang
    Beijing You An Hospital, Capital Medical University, Beijing 100069, People s Republic of China
    J Immunol 187:684-91. 2011

Collaborators

Detail Information

Publications6

  1. doi The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection
    Yonghong Zhang
    Beijing You An Hospital, Capital Medical University, Beijing, PR China
    Antiviral Res 92:247-54. 2011
    ..In this study, we evaluated the level of systemic cytokines and potential impact on combination therapy in both antiviral-naïve and -experienced patients chronically infected with hepatitis C virus...
  2. pmc Characteristics of CD8+ T cell subsets in Chinese patients with chronic HIV infection during initial ART
    Yanmei Jiao
    Center for Infectious Diseases, Beijing You An Hospital, Capital Medical University, Beijng 100069, China
    AIDS Res Ther 8:15. 2011
    ..abstract:..
  3. doi Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients
    Yonghong Zhang
    Beijing You An Hospital, Capital Medical University, Beijing, China
    Liver Int 32:102-9. 2012
    ..Virus-specific T-cell responses play a major role in antiviral immune response. However, the effect of hepatitis C virus (HCV)-specific T-cell responses on combination therapy still remains controversial...
  4. doi Potent hepatitis B surface antigen response to treatment of hepatitis-B-e-antigen-positive chronic hepatitis B with α-interferon plus a nucleos(t)ide analog
    Xinyue Chen
    Beijing You An Hospital, Capital Medical University, Beijing, China
    J Gastroenterol Hepatol 27:481-6. 2012
    ..The goal of this study was to investigate clinical features in chronic hepatitis B patients achieving seroconversion of HBsAg after treatment with α-interferon (IFN-α) and a nucleos(t)ide analog...
  5. doi Central memory CD4 cells are an early indicator of immune reconstitution in HIV/AIDS patients with anti-retroviral treatment
    Wei Hua
    Center for Infectious Diseases, Beijing You An Hospital, Capital Medical University, China
    Immunol Invest 41:1-14. 2012
    ..We conclude that CD4 CM cells are a major contributor to early immune reconstitution in treatment-naive HIV-infected patients with delayed ART, and might be an early indicator for immune reconstitution...
  6. pmc Multilayered defense in HLA-B51-associated HIV viral control
    Yonghong Zhang
    Beijing You An Hospital, Capital Medical University, Beijing 100069, People s Republic of China
    J Immunol 187:684-91. 2011
    ..We propose that patients with HLA-B51 benefit from having multiple layers of effective defense against the development of immune escape mutations...